Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women

Osteoporosis International

Volumn 17, Issue 9, 2006, Pages 1318-1328

  Faulkner, K A ^a   Cauley, J A ^a   Zmuda, J M ^a   Landsittel, D P ^b   Newman, A B ^a   Studenski, S A ^a   Redfern, M S ^a   Ensrud, K E ^c   Fink, H A ^c   Lane, N E ^d   Nevitt, M C ^e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcitropic hormones; Falls; Muscle strength; Neuromuscular function; Parathyroid hormone; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D;

AGED; ARTICLE; BLOOD ANALYSIS; BODY EQUILIBRIUM; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FALL RISK; FALLING; FEMALE; GRIP STRENGTH; HUMAN; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANDOMIZATION; REACTION TIME; SERUM; STANDING; TIME SERIES ANALYSIS; VITAMIN SUPPLEMENTATION; WALKING; WALKING SPEED;

ACCIDENTAL FALLS; AGED; CALCITRIOL; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MOTOR ACTIVITY; MUSCLE STRENGTH; PARATHYROID HORMONE; PSYCHOMOTOR PERFORMANCE; UNITED STATES; VITAMIN D;

EID: 33746417980     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-006-0071-8     Document Type: Article

References (48)

1. Bischoff HA, Borchers M, Gudat F et al (2001) In situ detection of the 1,25- dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19-24
2. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119:2214-2220
3. Birge SJ, Haddad JG (1975) 25-Hydroxycholecalciferol Stimulation of Muscle Metabolism. J Clin Invest 56:1100-1107
4. Prabahala A, Garg R, Dandona P (2000) Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 160:1199-1203
5. Rimaniol J-M, Authier F-J, Chariot P (1994) Muscle weakness in intensive care patients: initial manisfestation of vitamin D metabolites. Intensive Care Med 20:591-592
6. Delmont E, Roth S, Heudier P et al (2001) [Primary hyperparathyroidism, a differential diagnosis of motor neuron diseases.] Rev Med Interne 22:1253-1255
7. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG, Tobin JD (1995) Vitamin D deficiency in homebound elderly persons. JAMA 274:1683-1686
8. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1988) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783
9. Gloth FM, Smith CE, Hollis BW et al (1995) Functional improvement with vitamin D replishment in a cohort of frail, vitamin-D deficient older people. J Am Geriatr Soc 43:1269-1271
10. Dhesi JK, Jackson SH, Bearne LM et al (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33(6):589-595
11. Pfeifer M, Begerow B, Minne HW et al (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113-1118
12. Bischoff HA, Stahelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351
13. Flicker L, Macinnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Wark JD (2005) Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 53:1881-1888
14. Stein MS, Wark JD, Scherer SC et al (1999) Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 47(10):1195-1201
15. Sambrook PN, Chen JS, March LM et al (2003) Serum Parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 89:1572-1576
16. Visser M, Deeg DJ, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging study Amsterdam. J Clin Endocrinol Metab 88:5766-5772
17. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439-443
18. Vieth R, Ladak Y, Walfish P (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185-191
19. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004)Effect of vitamin D on falls. A meta-analysis. JAMA 291:1999-2006
20. Gallagher JC, Fowler SE, Detter JR (2001) Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618-3628
21. Dukas L, Bischoff HA, Lindpaintner LS et al (2004) Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 Mg daily. J Am Geriatr Soc 52:230-236
22. Kenny AM, Biskup B, Robbins B et al (2003) Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 51:1762-1767
23. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469-475
24. Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767-773
25. Cummings SR, Browner WS, Bauer D et al (1998) Endogenous sex and calciotropic hormones and the risk of hip and vertebral fractures: the study of osteoporotic fractures. N Engl J Med 339:733-738
26. Nevitt MC, Cummings SR, Kidd S et al (1989) Risk factors for recurrent non-syncopal falls. JAMA 261:2663-2668
27. Cummings SR, Block G, McHenry K et al (1987) Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol 126:796-802
28. Folstein MF, Robins LN, Helzer JE (1983) The Mini-Mental State Examination (letter). Arch Gen Psychiatry 40:812
29. Yaffe K, Lui L-Y, Grady D et al (2000) Cognitive decline in women in relation to non-protein bound oestradiol concentrations. Lancet 356:708-712
30. Bailey IL, Lovie JE (1976) New design principles for visual acuity letter charts. Am J Optom Physiol Opt 53:740-745
31. Lohman TG, Roche AF, Martorell R (1988) Anthropometric Standardization Reference Manual. 1st edn. Human Kinetics Books Champaign, Ill..
32. Chouchoud C, Pozet N, Labeeuw M et al (1999) Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kid Int 55:1878-1884
33. D'Agostino RB, Balanger A, D'Agostino RB Jr (1990) A suggestion for using powerful and informative tests of normality. Am Stat 44:316-321
34. Liang K-Y, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13-22
35. Gallagher JC (2004) The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 89-90:497-501
36. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ (2005) Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330:1003-1008
37. O'Loughlin JL, Robitaille Y, Boivin JF, Suissa S (1993) Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 137:342-354
38. Latham NK, Anderson CS, Reid IR (2003) Effects of Vitamin D Supplementation on Strength, Physical Performance, and Falls in Older Persons: A Systematic Review. J Am Geriatr Soc 51:1219-1226
39. Slovik DM, Adams JS, Neer RM et al (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372-374
40. Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:1420
41. Castillo L, Tanaka Y, DeLuca HF et al (1977) The stimulation of 25-hydroxy-vitamin D1-alpha-hydroxylase by estrogen. Arch Biochem Biophys 179:211217
42. Nesbitt T, Drezner MK (1993) Insulin-luce growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. Endocrinology 132:133-138
43. Dukas L, Schacht E, Stähelin HB (2002) Use of diuretics is associated with lower D-hormone serum levels but not with serum 25-hydroxyvitamin D in community-dwelling elderly men and women. Results from the baseline cross-sectional analyses of the Aims-Study. Osteoporos Int 13:875
44. Oelzner P, Müller A, Deschner F et al (1997) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 23:193198
45. Lau KHW, Baylink D (1999) Vitamin D therapy of osteoporosis: Plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 65:295-306
46. Bischoff HA, Borchers M, Gudat F et al (2001) In situ detection of 1,25-dihydroxyvitamin D receptor in human skeletal muscle tissue. Histochem J 33:19-24
47. Bischoff-Ferrari HA, Borchers M, Gidat F et al (2004) Vitamin D Receptor Expression in human muscle tissue decreases with age. J Bone Miner Res 19:265-269
48. Ganz DA, Higashi T, Rubenstein LZ (2005) Monitoring Falls in Cohort Studies of Community-Dwelling Older People: Effect of the Recall Interval. J Am Geriatr Soc 53:2190-2194